Olema Pharmaceuticals
OLMA
OLMA
67 hedge funds and large institutions have $81.2M invested in Olema Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $101M → $81.2M (-$20.2M)
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
Holders
67
Holding in Top 10
–
Calls
$101K
Puts
$8K
Top Buyers
| 1 | +$1.53M | |
| 2 | +$1.37M | |
| 3 | +$1.29M | |
| 4 |
JGC
J. Goldman & Co
New York
|
+$1.26M |
| 5 |
MAM
Monaco Asset Management
Monaco
|
+$407K |
Top Sellers
| 1 | -$9.13M | |
| 2 | -$3.4M | |
| 3 | -$706K | |
| 4 |
BlackRock
New York
|
-$634K |
| 5 |
Two Sigma Advisers
New York
|
-$387K |